gastrocon 2016 - acute liver failure
TRANSCRIPT
![Page 1: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/1.jpg)
ACUTE LIVER FAILURE
Dr Neerav GoyalSenior Consultant and HeadApollo Liver Transplant, Hepatobiliary and Pancreatic Surgery UnitIndraprastha Apollo Hospital, New Delhi
![Page 2: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/2.jpg)
• Introduction• Criteria• Pre transplant issues • Critical care management• When to offer &When to say No • Transplant outcome• Overall survival• Evidence
![Page 3: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/3.jpg)
ACUTE LIVER FAILURE• ALF is a life-threatening, rare medical
emergency that arises from massive acute hepatic necrosis
• Defined: 1. Presence of hepatocellular dysfunction
(coagulopathy, jaundice)2. Encephalopathy 3. No prior history of liver disease
![Page 4: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/4.jpg)
Definitions of ALF
![Page 5: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/5.jpg)
Which Definition to be followed?
![Page 6: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/6.jpg)
Definitions of ALF
Onset Defining event
Illness duration
Trey and Davidson, 1970
First symptoms Encephalopathy 8 weeks
Bernuau et al, 1986
Jaundice Encephalopathy 2 weeks-Fulminant2-12 weeks- Subfulminant
O’Grady et al,1993
Jaundice Encephalopathy 1 week- Hyperacute1-4 weeks-Acute5-12 weeks-Subacute
![Page 7: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/7.jpg)
• Interval between onset of acute hepatic injury (jaundice) and onset of liver failure (encephalopathy with or without coagulopathy (Icterus-encephalopathy interval; IEI)
• Between 4 weeks (Indian definition)2–4 to 24 weeks (AASLD–ALF study group)
![Page 8: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/8.jpg)
What is the significance of the jaundice to encephalopathy interval?
![Page 9: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/9.jpg)
![Page 10: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/10.jpg)
What is the significance of the grade of hepatic encephalopathy?
![Page 11: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/11.jpg)
Hepatic encephalopathy and spontaneous recovery
Trey C, CMAJ 1972
Survival Grade 2 HE Grade 3 HE Grade 4 HE
65-70% 40-50% <20%
![Page 12: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/12.jpg)
What are common etiological factors for ALF?
![Page 13: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/13.jpg)
![Page 14: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/14.jpg)
What are the main prognostic determinants in ALF?
![Page 15: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/15.jpg)
Prognostic Criteria• Four key determinants: 1. Aetiology2. Rate Of Progression Of The Disease3. Age Of The Patient4. Laboratory Markers Of Disease Severity
![Page 16: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/16.jpg)
![Page 17: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/17.jpg)
Kings College Hospital Criteria
![Page 18: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/18.jpg)
• Overall specificity of 82% for non-paracetamol aetiologies and 92–95% for paracetamol-related ALF
• Nonparacetamol aetiologies, involving 1105 patients in 18 studies
• Specificity increased to 93% in patients with more advanced encephalopathy
• 88% when the criteria were applied dynamically• Second meta-analysis of paracetamol-induced
ALF involved 8 studied and reported a specificity of 92% , sensitivity of 69%
![Page 19: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/19.jpg)
Reason for criteria
The probability of spontaneous recovery must be compared with the risks of surgery and immunosuppression
• King’s college hospital poor prognostic criteria• Clichy (Paris)criteria• Acute liver failure study group of Japan criteria• MELD score• ALF in-hospital mortality score (ALFIHMS)
![Page 20: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/20.jpg)
King’s vs MELD
![Page 21: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/21.jpg)
380 patients with ALF
ALF early dynamic (ALFED) model was constructed
Whether the levels of predictive variables remained persistently high or increased over 3 days above the discriminatory cut-off values
Demonstrated excellent discrimination with an area under the receiver operator characteristic curve of 0.91 & 0.92
![Page 22: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/22.jpg)
• ALFED score of > 4 had a high positive predictive value (85%) and negative predictive value (87%)
• Accurately predicted outcome in patients with ALF, which may be useful in clinical decision-making
![Page 23: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/23.jpg)
CASE 1
• Mr. X• 27/male• Jammu• Admitted with - History of jaundice for past 24 days- History of hepatic encephalopathy for past 3
days
![Page 24: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/24.jpg)
• No h/o any fever/prodromal symptoms/upper GI bleed / abdominal distension
• Patient was started on ATT following surgery for intestinal perforation (3 m back - Intensive Phase)
• H/o jaundice after 5 weeks• Stopped ATT however Jaundice continued to
increase• Developed Encephalopathy ~ 4 weeks following
jaundice
![Page 25: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/25.jpg)
Examination• PR- 130/min • BP-100/70 mm Hg • Temp: febrile (101 F) Icterus present • RS- NAD CVS-S1,S2 normal • CNS- Pupil dilated reacting to light• P/A: Soft, Non Distended, Non Tender,
Scar mark of previous surgery present, no e/o free fluid
![Page 26: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/26.jpg)
• ATT induced ALF- Which drugs are most reponsible?
• How often do you see DILI as a cause of ALF and which drugs in clinical practice?
![Page 27: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/27.jpg)
CASE 2
• Mr. D• 30/M• R/O Delhi• H/O Fever with prodromal symptoms for 10
days• Evaluated locally and found to be
jaundiced• Developed Encephalopathy 2 weeks after
initial symptoms
![Page 28: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/28.jpg)
• No history s/o CLD
• No comorbidity
• No h/o any substance abuse
• No h/o any previous surgery
![Page 29: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/29.jpg)
Examination• Comatose (Gr IV Encephalopathy)• Icterus +++• Pupil: B/L reacting• P: 107/min BP: 106/80 mm Hg RR:
20/min• RS/CVS:NAD• CNS: No e/o any focal neurological deficit• P/A: non distended/No organomegaly/No
e/o free fluid/ Liver Span ~10 cm
![Page 30: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/30.jpg)
• Gr IV Encephalopathy with INR 9.1 (Absolute Criteria)
• CT Brain: Normal• On etiological work up : Anti HEV I g M
(Positive)• Diagnosis : Fulminant Hepatic Failure (HEV
Related)
![Page 31: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/31.jpg)
Case 3• Master J• 7 Yr./M• R/o Nagpur• H/o vomiting and fever for 1 month• History of dark urine• Evaluated in a multispecialty hospital in
Nagpur and found to have deranged LFT along with coagulopathy (Referred)
![Page 32: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/32.jpg)
• Drowsy, Icterus +• Blood pressure – 160/80, Pulse – 72, RR –
24/min• RS/CVS:NAD• CNS: No e/o any focal neurological deficit• P/A: non distended/No organomegaly/No e/o
free fluid
![Page 33: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/33.jpg)
• Patient was admitted and evaluated• Hepatic encephalopathy(Gr 3) and INR was 7.5• S. Ceruloplasmin : 16.67• 24 urinary copper : High• KF rings +• CT liver Angio : essentially normal liver, patent PV
and minimal ascites• Diagnosed as acute Wilson’s disease • Family was counseled, prognosis explained &
advised regarding need of emergency liver transplant
• His encephalopathy worsened over night
![Page 34: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/34.jpg)
• Wilsons disease: Acute Liver Failure
![Page 35: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/35.jpg)
What are the goals of Management?
![Page 36: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/36.jpg)
Goals in ALF Managment
Intensive medical management1.
Identify patients not achieving sufficient liver regeneration
Emergency liver transplantation
2.
![Page 37: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/37.jpg)
• Major complications usually associated with death
1. Cerebral edema2. Seizures3. Infections4. Bleeding due to coagulopathy 5. Renal failure6. Electrolyte and acid base imbalance7. Hypoglycaemia
![Page 38: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/38.jpg)
Cerebral edema
• Cerebral edema Most common cause of mortality• ALF 58% have CE at admission• Mortality rate 82% with CE
44% without CE• Recent data suggest that cerebral edema is less
frequent- Acharya SK et al. Hepatology 2006
- O Grady et al.Lancet 2003
![Page 39: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/39.jpg)
Intracranial pressure
• Normal ICP: • 7–15 mmHg (supine), −10 mmHg (vertical position).
• CPP= MAP-ICP• Goals:
★ICP < 20–25 mm Hg.★CPP at 60–70 mm Hg
![Page 40: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/40.jpg)
Cerebral auto-regulation
ALF-loss of auto-regulation
![Page 41: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/41.jpg)
Should we measure ICP?
![Page 42: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/42.jpg)
Should we measure ICP?
• Survival of patients with grade III-IV HE not improved by ICP monitoring
• Vaquero J, Liver Transpl 2005• Keays RT, J Hepatol 1993
• Schmidt L, Crit Care Med 2006
• No information on long term neurological sequel
• Intracranial bleed in 10.3%
![Page 43: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/43.jpg)
Should we measure ICP?
Vaquero J, Liver Transpl 2005
• Frequent bedside clinical evaluation diagnose <25% episodes of ICH detected by ICP monitoring.
• Keays RT. J Hepatol 1993
![Page 44: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/44.jpg)
ICP monitoring- Is there a middle path?
• Ammonia levels• Jugular bulb oxygen saturation• Cerebral A-V difference of O2 saturation• Trans-cranial Doppler examination• Optic Nerve Sheath Diameter
![Page 45: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/45.jpg)
Any specifics for nursing care?
![Page 46: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/46.jpg)
Nursing care
• Head position- Neutral and 300 elevation
• Avoid stimulation• Treat fever aggressively
![Page 47: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/47.jpg)
What measure would you take to decrease ICP?
![Page 48: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/48.jpg)
Hyperosmolar therapy• Mannitol
• Hypertonic saline
• Surrogate goals in absence of ICP monitoring:
- Serum Osm 310-320 mOsm/Kg. - Serum sodium:145-150 mmol/L.
![Page 49: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/49.jpg)
Mannitol
• Response 15 to 60 min after bolus• In 20% paradoxical rise in ICP• Best in mild to moderate ICH• Better survival with mannitol (47.1% vs. 5.9%)
Canalese J. Gut
1982
![Page 50: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/50.jpg)
How to use mannitol in ALF?
• Use if preserved renal function.• Boluses iv. 0.25–0.5 g/kg when ICP >25
mmHg for >10 minutes.• Repeat if ICP remains > 25 mmHg and
serum osmolality < 310 mOsm/L.
![Page 51: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/51.jpg)
Hypertonic saline• Target level: 145-155 mmol/L• Monitor sodium every 6 hours• Correction <12 mmol/L in 24 hours or 16
mmol/L in 48 hours• Small RCT- incidence and severity of ICH
reduced in patients with induced hypernatremia
Murphy N, Wendon J. Hepatology 2004
![Page 52: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/52.jpg)
How to use hypertonic saline in ALF?
• 3% NS 250 cc bolus over 10-15 minutes (~4 cc/kg).
• Keep Na<160 and Osm<330 (?? upto 360).
• Problems- Hyperchloremic acidosis- Volume expansion.- Demyelination- Small brain hemorrhages- Aggravation of coagulopathy
![Page 53: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/53.jpg)
Barbiturates
• Thiopentone loading dose 3-5mg/kg (maximum 500mg) over 15 minutes, followed by a continuous infusion at 0.5-2.0mg/h
• Must be used with continuous ICP and arterial
BP monitoring
• ICP normalized in 8/12 with unresponsive ICT
Forbes et al. Hepatology 1989
![Page 54: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/54.jpg)
When not to use barbiturates in ALF?
• Problems:- Hypotension.- Anergy and poikilothermia- Hypokalemia
![Page 55: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/55.jpg)
Hypothermia
• Normalization of cerebral blood flow• ↓ Brain ammonia delivery/uptake• ↓ Anaerobic glycolysis & oxidative stress in astrocytes
• ↓ Brain ECF glutamate• External cooling blankets suffice
32o -35o C
![Page 56: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/56.jpg)
Hypothermia
- Cardiovascular instability- Shivering (paralysis needed)- Worsening coagulation- Reduced platelets- Increased infection risk- ? impairment of hepatic regeneration
![Page 57: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/57.jpg)
Ammonia and ICT
Kaplan-Meier plot of ICH in 165 ALF patients according to arterial ammonia on admission.
Bernal W. Hepatology 2007Clemmesen JO. Hepatology 1999
Arterial ammonia in 30 patients who did not develop CH and 14 patients who died from CH
![Page 58: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/58.jpg)
Role of Ammonia
Arterial ammonia levels >124 mmol/l 78.6% sensitive and 76.3% specific for predicting mortality
Bhatia V. Gut 2006
![Page 59: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/59.jpg)
Anti-ammonia measures• Lactulose• L-Ornithine L-Aspartate• Sodium Benzoate
![Page 60: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/60.jpg)
L-Ornithine L-Aspartate
Blinded RCT of LOLA vs. Placebo in ALF patients. 92 patients received LOLA, 93 received placebo
Acharya SK et al. Gastroenterology. 2009
![Page 61: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/61.jpg)
Hyperventilation
• Prophylactic hyperventilation no reduction in ICH
• pCO2 reduction to 25-30mm Hg decrease ICP once cerebral edema begins to develop
• Ede et al. J Hepatol 1986
• JVO2 monitoring mandatory.Normal JVO2: 60%-80%.
![Page 62: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/62.jpg)
What should be goals of cardiovascular management?
![Page 63: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/63.jpg)
Management of circulation- Goals
• Ensure adequate vascular filling (CVP: 8-12 cm water)
• Avoid over hydration and hypotonic fluids – increase in ICP
• Vasopressor agents (NorAdr) if MAP < 60 mmHg despite adequate fluids
• Hypotension in spite of above - a sign of bacterial or fungal sepsis
Goal: MAP > 60mmHg
![Page 64: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/64.jpg)
Choice of vasopressor
• Norepinephrine > Dopamine
• ? Terlipressin
• Avoid epinephrine
Steiner LA. Crit Care Med. 2004
![Page 65: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/65.jpg)
What role does NAC play?
![Page 66: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/66.jpg)
Gastroenterology. 2009 September ; 137(3): 856–864
![Page 67: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/67.jpg)
NAC dosing in non-acetaminophen ALF
• Initial loading dose of 150 mg/kg/hr over one hour
• Followed by 12.5 mg/kg/hour for 4 hours
• Then continuous infusions of 6.25 mg/kg for the remaining 67 hours (Total 72 hours)
![Page 68: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/68.jpg)
Prophylactic drugs usage?
![Page 69: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/69.jpg)
Prophylactic anti-seizure drugs
• Subclinical seizure activity- exacerbation of cerebral edema
• All patients with deep HE should be treated with prophylactic phenytoin
Ellis et al, Hepatology 2000
• RCT 42 ALF patients – no benefit Bhatia V, et
al. J Hepatol 2004
![Page 70: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/70.jpg)
Glucose homeostasis
100-200mg/dL<100mg/dL >200mg/dL
√X X
Hypoglycemia Infection risk
Increased cerebral lactate
![Page 71: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/71.jpg)
Correction of bleeding diathesis
• Clinically significant bleeding uncommon (<10%)
• Prophylactic FFP not recommended
• Maybe...• Profound coagulopathy (INR >7 with abnormal TEG) , FFP and cryoprecipitate transfusion to maintain INR between 5-7
![Page 72: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/72.jpg)
Infections in ALF-Consequences
1.Neurological deterioration
2.Aggravation of liver damage
3.Increased mortality
![Page 73: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/73.jpg)
Infection and neurological deterioration
DeterioratedImproved
100%
84.8%
15.2%
Infection during grade I-II HE predicts worsening HE
![Page 74: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/74.jpg)
Infection and mortality
n=268
p <0.001RR for mortality: 2.11 (1.54-2.90)Infection is an independent predictor of mortality
![Page 75: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/75.jpg)
Sites of infections in ALF
![Page 76: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/76.jpg)
Recommendations for managing renal failure?
![Page 77: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/77.jpg)
Renal failure• 40%–80% of patients • Associated with a poor prognosis• More frequently in acetaminophen induced
ALF (70%) and less frequently in ALF due to other causes (30%)
• Renal failure is reported in 10% of patients from India
- - Acharya SK et al. Hepatology 2006
- O Grady et al.Lancet 2003
![Page 78: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/78.jpg)
Role of CRRT and Bio-arteficial Liver Assist Devices ?
![Page 79: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/79.jpg)
Renal replacement therapy
• CRRT >IRRT (especially if cerebral edema)• Heparin avoided• Bicarbonate buffer preferred over citrate
and lactate• Biocompatible dialysis membranes like
polysulphone or polyacrylnitrate• Route Femoral• Avoid hyponatremia and other electrolyte
changes
![Page 80: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/80.jpg)
Artificial liver supportExcretory function
Synthetic and Biotransformatory
process
Dialysis √ (Ammonia) ×
Exchange transfusionPlasmapheresis
√ (Protein bound molecules) ×
Bioartificial extracorporeal devices √ √
Charcoal hemoperfusion
√ (Mercaptans, GABA, AAA,
and FA)×
Albumin dialysis √ ×
![Page 81: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/81.jpg)
Case 1: ATT induced ALF
King´s college Criteria
Age 28 N
Jaundice 27 mg/dl Y
INR 4.4 Y
Non A/Non B ATT Induced Y
Jaundice to encephalopathy
20 days Y
![Page 82: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/82.jpg)
HOSPITAL COURSE• Admitted in ICU as a referred case of acute
liver failure• At time of admission was fulfilling king`s
college criteria (4/5)• Features of severe sepsis
(fever/tachycardia/hypotension)• At time of admission was in grade 4
encephalopathy
![Page 83: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/83.jpg)
• Electively intubated and kept on ventilatory support
• For hypotension required inotropic support• Management started as per ALF protocol• Relatives appraised regarding patient
condition and need for optimization followed by liver transplant
• No potential donor in family
![Page 84: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/84.jpg)
• Patient condition continued to be critical• Persistent Hyper- bilirubinemia (Up to
57mg/dl) associated with coagulopathy(Up to 5.1)
• In view of no potential donor with detoriating liver and renal profile Plasmapheresis and CRRT started
• Required 3 sessions of plasmapheresis
![Page 85: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/85.jpg)
• Patient condition stabilized with improvement in liver and renal profile
• Inotropes were stopped• Extubated on day 9 when regained
sensorium• Shifted to ward after 2 weeks• Discharged after 25 days of admission with
serum bilirubin of 7 mg/dl• Doing well in follow up with completely
recovered liver profile
![Page 86: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/86.jpg)
When not to transplant?
![Page 87: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/87.jpg)
Contraindication for LT in ALF• Pt’s outside different prognostic criteria
• Active and resistant alcohol dependence/ substance abuse
• Documented previous history of noncompliance with medical or psychiatric therapy
• Medically unfit to survive LT• Brainstem Herniation• Active Sepsis
![Page 88: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/88.jpg)
• Under Went LRLT(Right lobe without MHV) with anterior sector reconstruction, Single duct (Duct to duct)
• Underwent uneventful surgery and was shifted to ICU
• POD 2 developed Intra abdominal bleed• Laparotomy done, Bleed from drain site• Extubated on POD 5
Case 2: Hep E
![Page 89: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/89.jpg)
• Immunosuppression started from POD 5• Shifted to ward on POD 9• Discharged on POD 19• Doing well on follow up
![Page 90: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/90.jpg)
Case-3: Fulminant Wilson’s• Under Went LRLT(Right lobe without MHV)
with anterior sector reconstruction, Single duct (Duct to duct)
• Uneventful surgery• Extubated POD1• In view of persistent drowsiness and fall in
saturation, he was re-intubated • Extubated on POD 4
![Page 91: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/91.jpg)
• Immunosuppression started from POD 2• Shifted to ward on POD 10• Uneventful Recovery• Discharged on POD 18• Doing well on regular follow up
![Page 92: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/92.jpg)
Outcome
![Page 93: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/93.jpg)
![Page 94: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/94.jpg)
• Results of liver transplantation for ALF are acceptable in the context of the severity of the illness and limited therapeutic alternative
• Survival rates at 1 year are 7% to 15% below those obtained for elective transplants in patients with chronic liver disease
• Compare favourably when compared with the 64.4% survival rate seen in patients in intensive care immediately prior to transplantation
• Relative risk of death was 1.6 3 months after liver transplantation - Mcphil M et al. Int Care Med 2009
![Page 95: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/95.jpg)
• Beyond the first year, the survival curve flattens out, so that in Europe at 10 years, the gap in survival between these 2 groups has fallen from 15% to 5%
• 1-year survival for deceased donor liver transplantation was 78.6%, and for living donor liver transplantation, it was 87%
- Merlon m et al.AJT 2008
![Page 96: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/96.jpg)
LDLT in ALF• Safe and effective alternative • Survival comparable to DDLT• Less infectious complication in recipient• Less waiting time• Good graft quality from healthy donor
![Page 97: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/97.jpg)
P=0.21 NS
P=0.001
![Page 98: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/98.jpg)
LDLT vs DDLT
Outcome of 14 patients with acute liver failure evaluated for LDLT. Abbreviations: DDLT, deceased donor liver transplantation; LD, living donor; LDLT, living donor liver transplantation; txp, transplant
![Page 99: Gastrocon 2016 - Acute Liver Failure](https://reader036.vdocuments.us/reader036/viewer/2022062412/587e6a3b1a28ab2a538b7c89/html5/thumbnails/99.jpg)
• Results of living donor liver transplantation for ALF in a Japanese experience of 42 patients were very comparable to overall outcomes
• 80% 1-year survival and 68% 10- year survival• Study indicated that the results were
influenced by the ratio of the graft to standard liver volume
• 1-year survival rate of 87.1% in those with a ratio 50% versus 80.7% in those with volumes in the 40% to 50% range
- Kayishama H JACS 2008- Lee SG et al . Journ Hepat 2007